Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
24
CNMD Quote, Financials, Valuation and Earnings
Last price:
$49.23
Seasonality move
:
0.65%
Day range:
$49.06 - $50.50
52-week range:
$46.00 - $78.19
Dividend yield:
1.62%
P/E ratio:
12.96x
P/S ratio:
1.17x
P/B ratio:
1.56x
Volume:
537.4K
Avg. volume:
417.7K
1-year change:
-33.08%
Market cap:
$1.5B
Revenue:
$1.3B
EPS (TTM):
$3.80
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $862.5M | $1B | $1B | $1.2B | $1.3B | |
| Revenue Growth (YoY) | -9.7% | 17.18% | 3.45% | 19.06% | 5% | |
| Cost of Revenues | $402.2M | $442.6M | $474.2M | $568.5M | $574M | |
| Gross Profit | $460.3M | $568M | $571.2M | $676.2M | $733M | |
| Gross Profit Margin | 53.37% | 56.21% | 54.64% | 54.33% | 56.08% | |
| R&D Expenses | $40.5M | $43.6M | $47.2M | $52.6M | $54.4M | |
| Selling, General & Admin | $373.8M | $414.8M | $454M | $503M | $478.3M | |
| Other Inc / (Exp) | -$355K | -$1.1M | -$112M | -- | -- | |
| Operating Expenses | $414.3M | $458.3M | $501.2M | $555.6M | $532.7M | |
| Operating Income | $46M | $109.7M | $70.1M | $120.6M | $200.3M | |
| Net Interest Expenses | $44.1M | $35.5M | $28.9M | $39.8M | $37.3M | |
| EBT. Incl. Unusual Items | $1.6M | $73.1M | -$70.9M | $80.8M | $163M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$7.9M | $10.6M | $9.7M | $16.4M | $30.6M | |
| Net Income to Company | $9.5M | $62.5M | -$80.6M | $64.5M | $132.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $9.5M | $62.5M | -$80.6M | $64.5M | $132.4M | |
| Basic EPS (Cont. Ops) | $0.33 | $2.14 | -$2.68 | $2.10 | $4.29 | |
| Diluted EPS (Cont. Ops) | $0.32 | $1.94 | -$2.68 | $2.04 | $4.25 | |
| Weighted Average Basic Share | $28.6M | $29.2M | $30M | $30.7M | $30.8M | |
| Weighted Average Diluted Share | $29.5M | $32.2M | $30M | $31.5M | $31.2M | |
| EBITDA | $118.3M | $179.3M | $27.6M | $192.5M | $272.2M | |
| EBIT | $45.7M | $108.6M | -$42M | $120.6M | $200.3M | |
| Revenue (Reported) | $862.5M | $1B | $1B | $1.2B | $1.3B | |
| Operating Income (Reported) | $46M | $109.7M | $70.1M | $120.6M | $200.3M | |
| Operating Income (Adjusted) | $45.7M | $108.6M | -$42M | $120.6M | $200.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $232.7M | $242.3M | $295.5M | $312.3M | $321.3M | |
| Revenue Growth (YoY) | 8.72% | 4.15% | 21.93% | 5.69% | 2.88% | |
| Cost of Revenues | $104.2M | $106.3M | $140.1M | $140.3M | $143.5M | |
| Gross Profit | $128.4M | $136M | $155.3M | $172M | $177.8M | |
| Gross Profit Margin | 55.21% | 56.12% | 52.57% | 55.07% | 55.33% | |
| R&D Expenses | $10M | $10.7M | $12.5M | $13.6M | $12.9M | |
| Selling, General & Admin | $98.3M | $102.9M | $130.1M | $123.4M | $148.8M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $108.4M | $113.5M | $142.6M | $137M | $161.8M | |
| Operating Income | $20.1M | $22.4M | $12.7M | $35M | $16M | |
| Net Interest Expenses | $10.4M | $5M | $10.3M | $9.6M | $8.3M | |
| EBT. Incl. Unusual Items | $9.7M | $17.4M | $2.4M | $25.4M | $7.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$129K | $2.5M | $625K | $5.7M | $1.6M | |
| Net Income to Company | $9.9M | $15M | $1.8M | $19.7M | $6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $9.9M | $15M | $1.8M | $19.7M | $6M | |
| Basic EPS (Cont. Ops) | $0.34 | $0.51 | $0.06 | $0.64 | $0.19 | |
| Diluted EPS (Cont. Ops) | $0.31 | $0.47 | $0.06 | $0.63 | $0.19 | |
| Weighted Average Basic Share | $29M | $29.4M | $30.5M | $30.8M | $31M | |
| Weighted Average Diluted Share | $31.4M | $35.2M | $31.2M | $31.3M | $31.2M | |
| EBITDA | $38.4M | $39.3M | $30.6M | $53.1M | $34.2M | |
| EBIT | $20.1M | $22.4M | $12.7M | $35M | $16M | |
| Revenue (Reported) | $232.7M | $242.3M | $295.5M | $312.3M | $321.3M | |
| Operating Income (Reported) | $20.1M | $22.4M | $12.7M | $35M | $16M | |
| Operating Income (Adjusted) | $20.1M | $22.4M | $12.7M | $35M | $16M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $881.1M | $1B | $1.1B | $1.3B | $1.3B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $411.5M | $444.7M | $508M | $568.7M | $577.2M | |
| Gross Profit | $469.6M | $575.6M | $590.6M | $692.9M | $738.8M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $40.4M | $44.2M | $49M | $53.7M | $53.8M | |
| Selling, General & Admin | $376.3M | $419.3M | $481.2M | $496.3M | $503.8M | |
| Other Inc / (Exp) | -$267K | -$1.1M | -$112M | -- | -- | |
| Operating Expenses | $416.7M | $463.5M | $530.3M | $550M | $557.5M | |
| Operating Income | $52.9M | $112.1M | $60.3M | $142.9M | $181.3M | |
| Net Interest Expenses | $44.8M | $30.1M | $34.2M | $39.1M | $36M | |
| EBT. Incl. Unusual Items | $7.8M | $80.8M | -$85.9M | $103.8M | $145.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$5.6M | $13.2M | $7.9M | $21.5M | $26.5M | |
| Net Income to Company | $13.5M | $67.7M | -$93.7M | $82.3M | $118.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $13.5M | $67.7M | -$93.7M | $82.3M | $118.8M | |
| Basic EPS (Cont. Ops) | $0.46 | $2.31 | -$3.21 | $2.69 | $3.84 | |
| Diluted EPS (Cont. Ops) | $0.39 | $2.10 | -$3.25 | $2.61 | $3.80 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $125.1M | $180.2M | $18.9M | $214.9M | $253.3M | |
| EBIT | $52.7M | $111M | -$51.7M | $142.9M | $181.3M | |
| Revenue (Reported) | $881.1M | $1B | $1.1B | $1.3B | $1.3B | |
| Operating Income (Reported) | $52.9M | $112.1M | $60.3M | $142.9M | $181.3M | |
| Operating Income (Adjusted) | $52.7M | $111M | -$51.7M | $142.9M | $181.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $232.7M | $242.3M | $295.5M | $312.3M | $321.3M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $104.2M | $106.3M | $140.1M | $140.3M | $143.5M | |
| Gross Profit | $128.4M | $136M | $155.3M | $172M | $177.8M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $10M | $10.7M | $12.5M | $13.6M | $12.9M | |
| Selling, General & Admin | $98.3M | $102.9M | $130.1M | $123.4M | $148.8M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $108.4M | $113.5M | $142.6M | $137M | $161.8M | |
| Operating Income | $20.1M | $22.4M | $12.7M | $35M | $16M | |
| Net Interest Expenses | $10.4M | $5M | $10.3M | $9.6M | $8.3M | |
| EBT. Incl. Unusual Items | $9.7M | $17.4M | $2.4M | $25.4M | $7.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$129K | $2.5M | $625K | $5.7M | $1.6M | |
| Net Income to Company | $9.9M | $15M | $1.8M | $19.7M | $6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $9.9M | $15M | $1.8M | $19.7M | $6M | |
| Basic EPS (Cont. Ops) | $0.34 | $0.51 | $0.06 | $0.64 | $0.19 | |
| Diluted EPS (Cont. Ops) | $0.31 | $0.47 | $0.06 | $0.63 | $0.19 | |
| Weighted Average Basic Share | $29M | $29.4M | $30.5M | $30.8M | $31M | |
| Weighted Average Diluted Share | $31.4M | $35.2M | $31.2M | $31.3M | $31.2M | |
| EBITDA | $38.4M | $39.3M | $30.6M | $53.1M | $34.2M | |
| EBIT | $20.1M | $22.4M | $12.7M | $35M | $16M | |
| Revenue (Reported) | $232.7M | $242.3M | $295.5M | $312.3M | $321.3M | |
| Operating Income (Reported) | $20.1M | $22.4M | $12.7M | $35M | $16M | |
| Operating Income (Adjusted) | $20.1M | $22.4M | $12.7M | $35M | $16M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $27.4M | $20.8M | $28.9M | $24.3M | $24.5M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $177.2M | $183.9M | $191.3M | $242.3M | $237.7M | |
| Inventory | $194.9M | $231.6M | $332.3M | $318.3M | $346.7M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $17.3M | $23.8M | $28.6M | $30.8M | $31.1M | |
| Total Current Assets | $416.7M | $460.1M | $581.2M | $615.6M | $640M | |
| Property Plant And Equipment | $111.4M | $108.9M | $115.6M | $120.7M | $115.8M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $618.4M | $617.5M | $815.4M | $806.8M | $805.4M | |
| Other Intangibles | $501.5M | $471M | $681.8M | $649.5M | $617.7M | |
| Other Long-Term Assets | $96.8M | $98.8M | $93.9M | $96.1M | $116.4M | |
| Total Assets | $1.8B | $1.8B | $2.3B | $2.3B | $2.3B | |
| Accounts Payable | $53.3M | $58.2M | $73.4M | $88.2M | $102.2M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $68.3M | $65.7M | $98.7M | $151.7M | $109.8M | |
| Total Current Liabilities | $190.2M | $196.6M | $296.6M | $310.7M | $278.1M | |
| Long-Term Debt | $735.2M | $672.4M | $985.1M | $973.1M | $905.1M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1B | $980.6M | $1.6B | $1.5B | $1.3B | |
| Common Stock | $313K | $313K | $313K | $313K | $313K | |
| Other Common Equity Adj | -$63.7M | -$54.2M | -$57.9M | -$50.2M | -$58.9M | |
| Common Equity | $709M | $785.4M | $745.5M | $834.2M | $962.7M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $709M | $785.4M | $745.5M | $834.2M | $962.7M | |
| Total Liabilities and Equity | $1.8B | $1.8B | $2.3B | $2.3B | $2.3B | |
| Cash and Short Terms | $27.4M | $20.8M | $28.9M | $24.3M | $24.5M | |
| Total Debt | $753.6M | $684.7M | $1.1B | $973.8M | $905.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $36.8M | $24.9M | $26.5M | $33.9M | $35.5M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $164M | $183.2M | $213.2M | $241.5M | $221.1M | |
| Inventory | $205.8M | $253.7M | $335.4M | $322.3M | $354.7M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $17.8M | $26.5M | $35M | $38.1M | $27.7M | |
| Total Current Assets | $424.4M | $488.3M | $610.1M | $635.7M | $639M | |
| Property Plant And Equipment | $109.4M | $108.5M | $115.4M | $118M | $116.1M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $618.1M | $617.5M | $815.5M | $806.3M | $805.7M | |
| Other Intangibles | $493.9M | $463.4M | $673.5M | $641.3M | $609.8M | |
| Other Long-Term Assets | $100.9M | $107.9M | $105.6M | $108M | $127.1M | |
| Total Assets | $1.7B | $1.8B | $2.3B | $2.3B | $2.3B | |
| Accounts Payable | $55.8M | $67.5M | $76.7M | $101.6M | $95.7M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $65.4M | $62.5M | $124.9M | $139.1M | $129M | |
| Total Current Liabilities | $182.2M | $187.6M | $320.7M | $291.4M | $283.1M | |
| Long-Term Debt | $725.3M | $703.5M | $995.3M | $990.1M | $891.4M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1B | $996.2M | $1.6B | $1.5B | $1.3B | |
| Common Stock | $313K | $313K | $313K | $313K | $313K | |
| Other Common Equity Adj | -$62.8M | -$52.8M | -$55M | -$49.8M | -$57.4M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $725.6M | $789.5M | $752.5M | $854.7M | $977.6M | |
| Total Liabilities and Equity | $1.7B | $1.8B | $2.3B | $2.3B | $2.3B | |
| Cash and Short Terms | $36.8M | $24.9M | $26.5M | $33.9M | $35.5M | |
| Total Debt | $745.4M | $715.8M | $1.1B | $990.8M | $892.2M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $9.5M | $62.5M | -$80.6M | $64.5M | $132.4M | |
| Depreciation & Amoritzation | $72.6M | $70.7M | $69.5M | $71.9M | $71.9M | |
| Stock-Based Compensation | $13.1M | $16.3M | $21.7M | $24.3M | $25.6M | |
| Change in Accounts Receivable | $13.9M | -$9.2M | -$5.2M | -$47.1M | -$1.6M | |
| Change in Inventories | -$30.4M | -$37.8M | -$78.6M | $14.1M | -$31.6M | |
| Cash From Operations | $64.5M | $111.8M | $33.4M | $125.3M | $167M | |
| Capital Expenditures | $13M | $14.9M | $21.8M | $19M | $13.1M | |
| Cash Acquisitions | -$3.9M | -- | -$227.7M | -- | -- | |
| Cash From Investing | -$13.6M | -$14.9M | -$249.5M | -$20M | -$13.1M | |
| Dividends Paid (Ex Special Dividend) | -$22.8M | -$23.3M | -$24M | -$24.5M | -$24.7M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $199M | $379.2M | $1.3B | $692M | $751M | |
| Long-Term Debt Repaid | -$225.3M | -$460.4M | -$898M | -$780M | -$823M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$3M | $3M | -$115.5M | $2.1M | -$54.3M | |
| Cash From Financing | -$52.1M | -$101.5M | $225M | -$110.4M | -$151M | |
| Beginning Cash (CF) | $25.9M | $27.4M | $20.8M | $28.9M | $24.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$1.2M | -$4.6M | $8.8M | -$5.1M | $2.9M | |
| Ending Cash (CF) | $27.4M | $20.8M | $28.9M | $24.3M | $24.5M | |
| Levered Free Cash Flow | $51.5M | $96.9M | $11.6M | $106.3M | $153.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $9.9M | $15M | $1.8M | $19.7M | $6M | |
| Depreciation & Amoritzation | $18.3M | $16.8M | $17.9M | $18M | $18.3M | |
| Stock-Based Compensation | $3.4M | $4.5M | $5.7M | $6.2M | $13.9M | |
| Change in Accounts Receivable | $12M | -$163K | -$20.7M | -$908K | $19M | |
| Change in Inventories | -$11.6M | -$21.9M | -$3M | -$5M | -$7.5M | |
| Cash From Operations | $22.3M | $328K | -$3.8M | $29.1M | $41.5M | |
| Capital Expenditures | $3.1M | $3.7M | $4.3M | $2M | $3.8M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$3.1M | -$3.7M | -$4.3M | -$2M | -$2.9M | |
| Dividends Paid (Ex Special Dividend) | -$5.8M | -$5.9M | -$6.1M | -$6.2M | -$6.2M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $64M | $110M | $173M | $254M | $166M | |
| Long-Term Debt Repaid | -$75.3M | -$102M | -$164M | -$238M | -$180.6M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $8.2M | $5.3M | $2.4M | -$26.9M | -$7.6M | |
| Cash From Financing | -$8.9M | $7.5M | $5.4M | -$17M | -$28.4M | |
| Beginning Cash (CF) | $27.4M | $20.8M | $28.9M | $24.3M | $24.5M | |
| Foreign Exchange Rate Adjustment | -$950K | -$113K | $303K | -$513K | $819K | |
| Additions / Reductions | $10.4M | $4.1M | -$2.8M | $10.1M | $10.2M | |
| Ending Cash (CF) | $36.8M | $24.9M | $26.5M | $33.9M | $35.5M | |
| Levered Free Cash Flow | $19.2M | -$3.4M | -$8.1M | $27.1M | $37.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $13.5M | $67.7M | -$93.7M | $82.3M | $118.8M | |
| Depreciation & Amoritzation | $72.5M | $69.3M | $70.6M | $72M | $72.1M | |
| Stock-Based Compensation | $13.5M | $17.4M | $23M | $24.8M | $33.2M | |
| Change in Accounts Receivable | $6.8M | -$21.3M | -$25.7M | -$27.3M | $18.3M | |
| Change in Inventories | -$29.7M | -$48M | -$59.7M | $12M | -$34.1M | |
| Cash From Operations | $83.2M | $89.8M | $29.2M | $158.3M | $179.4M | |
| Capital Expenditures | $13.3M | $15.4M | $22.4M | $16.8M | $14.8M | |
| Cash Acquisitions | -- | -- | -$227.7M | -- | -- | |
| Cash From Investing | -$10.1M | -$15.4M | -$250.1M | -$17.8M | -$14M | |
| Dividends Paid (Ex Special Dividend) | -$22.9M | -$23.4M | -$24.2M | -$24.6M | -$24.7M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $204M | $425.2M | $1.3B | $773M | $663M | |
| Long-Term Debt Repaid | -$256.3M | -$487.1M | -$960M | -$854M | -$765.6M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $11.5M | $79K | -$118.4M | -$27.2M | -$35.1M | |
| Cash From Financing | -$63.7M | -$85.2M | $222.9M | -$132.8M | -$162.4M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $9.4M | -$10.9M | $2M | $7.7M | $3M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $69.9M | $74.3M | $6.8M | $141.5M | $164.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $9.9M | $15M | $1.8M | $19.7M | $6M | |
| Depreciation & Amoritzation | $18.3M | $16.8M | $17.9M | $18M | $18.3M | |
| Stock-Based Compensation | $3.4M | $4.5M | $5.7M | $6.2M | $13.9M | |
| Change in Accounts Receivable | $12M | -$163K | -$20.7M | -$908K | $19M | |
| Change in Inventories | -$11.6M | -$21.9M | -$3M | -$5M | -$7.5M | |
| Cash From Operations | $22.3M | $328K | -$3.8M | $29.1M | $41.5M | |
| Capital Expenditures | $3.1M | $3.7M | $4.3M | $2M | $3.8M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$3.1M | -$3.7M | -$4.3M | -$2M | -$2.9M | |
| Dividends Paid (Ex Special Dividend) | -$5.8M | -$5.9M | -$6.1M | -$6.2M | -$6.2M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $64M | $110M | $173M | $254M | $166M | |
| Long-Term Debt Repaid | -$75.3M | -$102M | -$164M | -$238M | -$180.6M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $8.2M | $5.3M | $2.4M | -$26.9M | -$7.6M | |
| Cash From Financing | -$8.9M | $7.5M | $5.4M | -$17M | -$28.4M | |
| Beginning Cash (CF) | $27.4M | $20.8M | $28.9M | $24.3M | $24.5M | |
| Foreign Exchange Rate Adjustment | -$950K | -$113K | $303K | -$513K | $819K | |
| Additions / Reductions | $10.4M | $4.1M | -$2.8M | $10.1M | $10.2M | |
| Ending Cash (CF) | $36.8M | $24.9M | $26.5M | $33.9M | $35.5M | |
| Levered Free Cash Flow | $19.2M | -$3.4M | -$8.1M | $27.1M | $37.8M | |
Get CNMD Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CNMD
Sector
P/E ratio
12.96x
24.07x
PEG ratio
0.28x
0.00x
P/B ratio
1.56x
1.81x
Price / LTM sales
1.17x
1.67x
Growth Metrics
CNMD
Sector
Revenue growth
2.88%
4.06%
Earnings growth
-69.84%
7.49%
Revenue (5-year growth)
6.48%
8.01%
Earnings forecast
$1.12
-$0.20
Profitability
CNMD
Sector
Profitability FY 2024
$733M
$47.5M
Return on invested capital
6.38%
-16.26%
Return on assets
5.16%
-13.27%
Return on equity
12.88%
-18.61%
Earnings Date
Last Earnings Date
Apr
30
Next Earnings Date
Jul
30
Estimated Next Earnings Date
Jul
30
Balance Sheet
CNMD
Sector
Total cash
$35.5M
$35.7M
Short term investments
--
$29.7M
Total assets
$2.3B
$106.9M
Long term debt
$892.2M
$7.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
